Exciting Opportunity: Join the Ambry Rare Disease Sales Team!

Comparably Awards

Recently acquired by Tempus Labs, Ambry Genetics excels at translating scientific research into clinically actionable test results based on a deep understanding of the human genome and the biology behind genetic disease. We care about what happens to real people, their families, and the people they love. Our team is dedicated to providing them and their clinicians with deeper knowledge and fresh insights, so together they can make informed, potentially life-altering healthcare decisions. read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 537

TOTAL RATINGS: 15509

CEO: Tom Schoenherr

Tom Schoenherr Ambry Genetics CEO Rating

Ambry Genetics' CEO, Tom Schoenherr, has 538 employee ratings and a score of 84/100, placing them in the Top 5% of similar size companies on Comparably with 501-1,000 Employees and Top 5% of other companies in Los Angeles. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at Ambry Genetics rate Tom Schoenherr higher than non-binary employees, giving the CEO a score of 87/100.

Last updated a month ago.

Where This Score Ranks Ambry Genetics' CEO Rating

TOP
5%
In the Top 5% of 1832 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 403 Nearby Companies in Los Angeles
1st
1st place versus 4 competitors rated on Comparably

May

Jun

Aug

Oct

Nov

A+84 / 100

Jan

Ambry Genetics CEO Tom Schoenherr Bio

Tom Schoenherr is responsible for the strategic, financial, and operational leadership of Ambry Genetics.

Tom joined Ambry in 2017 as Chief Commercial Officer and was responsible for the execution of Ambry’s go-to-market strategy and overseeing all commercial functions including service, support, sales, marketing, business development, managed care, and genetic specialists. Prior to Ambry, Tom spent more than 20 years in leadership positions in the molecular diagnostics space, most recently as the CCO of Omada Health where he was responsible for driving business growth and increasing market share. He also served in similar roles at Counsyl, Quest Diagnostics, Siemens Healthcare, and Abbott Diagnostics. Tom earned his BS from Michigan State University and completed his Executive Business Development Program from the University of Notre Dame.

Who Ranks Ambry Genetics' CEO Rating the Highest?

Department - Legal 100/100

Department - Business Development 96/100

Department - Sales 94/100

Who Ranks Ambry Genetics' CEO Rating the Lowest?

Gender - Non-Binary 61/100

Ethnicity - Other 75/100

Department - Admin 77/100

Ambry Genetics CEO Tom Schoenherr At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Ambry Genetics.

Based on 538 ratings, Tom Schoenherr ranks right above Recombine's CEO, Alexander Bisignano.

Ambry Genetics' CEO is highly regarded by the Legal department, the Business Development department, and the Sales department. However, Non-Binary employees and the Admin department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.